In an official statement sent to the Central Institute of Hygiene and Epidemiology on April 28, the Department of Preventive Medicine (Ministry of Health) said that the Advisory Board of the Ministry of Health on the Use of Vaccines had met and agreed to host the second to inject a booster vaccine. Nose 4) at least 4 months after nose 3 in some subjects.
In addition, the person who received the 3rd injection is infected COVID-19 then 3 months after recovery from the disease the 4th injection.
The Department of Preventive Medicine also noted the case of 4 injections in people aged 50 and over. People 18 years and older with moderate to severe immunodeficiency, people 18 years and older who belong to the high-risk group for COVID-19 exposure (healthcare workers, front-line workers, workers in industrial parks, etc. Karma).
Selected vaccines include mRNA vaccine (Pfizer or Moderna) and AstraZeneca vaccine or dose 3 vaccine of the same type.
As of 2:30 p.m. on April 29, the country had injected more than 214.5 million doses of the COVID-19 vaccine. Of these, 887,447 doses were injected on April 28, more than the previous days. The coverage rate of nose 1 and 2 in people over 18 years old is 100%; Point 3 is 56.2%; The coverage rate of nose 1 and 2 in children aged 12-17 is 100% and 96.4%, respectively.
Number Covid-19 vaccination 195,130,575 doses were administered to persons aged 18 and over, of which the first dose is 71,442,983 doses; Nose 2: 70,126,854 doses; additional dose: 15,225,865 doses and third dose: 38,334,871 doses.
The number of doses of COVID-19 vaccine administered to children aged 12 to 17 is 17,364,318 doses, 1st dose: 8,896,548 doses and 2nd dose: 8,467,770 doses.
Regarding the vaccination against COVID-19 for children aged 5 to 11, by the end of April, after half a month of carrying out the vaccination campaign for children in this age group, 60/63 provinces and cities have been vaccinated and there are daily reports on vaccination. Ministry of Health. Accordingly, more than 1.15 million doses have been safely administered to children aged 5 to 11 years.